BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21215903)

  • 1. Control of caseous lymphadenitis.
    Windsor PA
    Vet Clin North Am Food Anim Pract; 2011 Mar; 27(1):193-202. PubMed ID: 21215903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of caseous lymphadenitis and usage of caseous lymphadenitis vaccines in sheep flocks.
    Paton MW; Walker SB; Rose IR; Watt GF
    Aust Vet J; 2003; 81(1-2):91-5. PubMed ID: 15084020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunisation against ovine caseous lymphadenitis: comparison of Corynebacterium pseudotuberculosis vaccines with and without bacterial cells.
    Eggleton DG; Middleton HD; Doidge CV; Minty DW
    Aust Vet J; 1991 Oct; 68(10):317-9. PubMed ID: 1755781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A field trial to evaluate a whole cell vaccine for the prevention of caseous lymphadenitis in sheep and goat flocks.
    Menzies PI; Muckle CA; Brogden KA; Robinson L
    Can J Vet Res; 1991 Oct; 55(4):362-6. PubMed ID: 1790493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunisation against ovine caseous lymphadenitis: efficacy of monocomponent Corynebacterium pseudotuberculosis toxoid vaccine and combined clostridial-corynebacterial vaccines.
    Eggleton DG; Doidge CV; Middleton HD; Minty DW
    Aust Vet J; 1991 Oct; 68(10):320-1. PubMed ID: 1755782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigens of Corynebacterium pseudotuberculosis and prospects for vaccine development.
    Dorella FA; Pacheco LG; Seyffert N; Portela RW; Meyer R; Miyoshi A; Azevedo V
    Expert Rev Vaccines; 2009 Feb; 8(2):205-13. PubMed ID: 19196200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence of caseous lymphadenitis in Alberta sheep and assessment of impact by vaccination with commercial and experimental vaccines.
    Stanford K; Brogden KA; McClelland LA; Kozub GC; Audibert F
    Can J Vet Res; 1998 Jan; 62(1):38-43. PubMed ID: 9442938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spread of Corynebacterium pseudotuberculosis infection to unvaccinated and vaccinated sheep.
    Paton MW; Sutherland SS; Rose IR; Hart RA; Mercy AR; Ellis TM
    Aust Vet J; 1995 Jul; 72(7):266-9. PubMed ID: 8534231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of antibody to caseous lymphadenitis in ewes on the efficacy of vaccination in lambs.
    Paton MW; Mercy AR; Sutherland SS; Ellis TM; Duda SR
    Aust Vet J; 1991 Apr; 68(4):143-6. PubMed ID: 2069543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunisation against ovine caseous lymphadenitis: correlation between Corynebacterium pseudotuberculosis toxoid content and protective efficacy in combined clostridial-corynebacterial vaccines.
    Eggleton DG; Haynes JA; Middleton HD; Cox JC
    Aust Vet J; 1991 Oct; 68(10):322-5. PubMed ID: 1755783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological response of vaccinated sheep after challenge with Corynebacterium pseudotuberculosis.
    Sutherland SS; Ellis TM; Paton MJ; Mercy AR
    Aust Vet J; 1992 Jul; 69(7):168-9. PubMed ID: 1445082
    [No Abstract]   [Full Text] [Related]  

  • 12. Vaccination confers significant protection of sheep against infection with a virulent United Kingdom strain of Corynebacterium pseudotuberculosis.
    Fontaine MC; Baird G; Connor KM; Rudge K; Sales J; Donachie W
    Vaccine; 2006 Aug; 24(33-34):5986-96. PubMed ID: 16806606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of an ovine caseous lymphadenitis vaccine formulated using a genetically inactive form of the Corynebacterium pseudotuberculosis phospholipase D.
    Hodgson AL; Carter K; Tachedjian M; Krywult J; Corner LA; McColl M; Cameron A
    Vaccine; 1999 Feb; 17(7-8):802-8. PubMed ID: 10067685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caseous lymphadenitis: an increasing cause for concern.
    Winter AC
    Vet Rec; 1997 Jun; 140(23):611. PubMed ID: 9203323
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of Corynebacterium pseudotuberculosis recombinant proteins rCP09720 or rCP01850 with rPLD as immunogens in caseous lymphadenitis immunoprophylaxis.
    Silva MTO; Bezerra FSB; de Pinho RB; Begnini KR; Seixas FK; Collares T; Portela RD; Azevedo V; Dellagostin O; Borsuk S
    Vaccine; 2018 Jan; 36(1):74-83. PubMed ID: 29174312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines for caseous lymphadenitis: up-to-date and forward-looking strategies.
    de Pinho RB; de Oliveira Silva MT; Bezerra FSB; Borsuk S
    Appl Microbiol Biotechnol; 2021 Mar; 105(6):2287-2296. PubMed ID: 33651132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The control of Corynebacterium pseudotuberculosis infection in sheep flocks: a mathematical model of the impact of vaccination, serological testing, clinical examination and lancing of abscesses.
    O'Reilly KM; Medley GF; Green LE
    Prev Vet Med; 2010 Jun; 95(1-2):115-26. PubMed ID: 20304509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of caseous lymphadenitis on wool production and bodyweight in young sheep.
    Paton MW; Mercy AR; Wilkinson FC; Gardner JJ; Sutherland SS; Ellis TM
    Aust Vet J; 1988 Apr; 65(4):117-9. PubMed ID: 3390089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corynebacterium pseudotuberculosis and its role in ovine caseous lymphadenitis.
    Baird GJ; Fontaine MC
    J Comp Pathol; 2007 Nov; 137(4):179-210. PubMed ID: 17826790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Corynebacterium pseudotuberculosis bacterin for the immunologic protection of sheep against development of caseous lymphadenitis.
    LeaMaster BR; Shen DT; Gorham JR; Leathers CW; Wells HD
    Am J Vet Res; 1987 May; 48(5):869-72. PubMed ID: 3592392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.